KIMBERLY JAKEWAY: Open Payments
NPI 1598278111 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 13 payments from 8 companies in 2025. Trend: 2023 $184 · 2024 $246 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Paratek Pharmaceuticals, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $45 |
| Eisai Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| SI-BONE, INC. | 1 | $15 |
Products named: Veozah, FARXIGA, NUZYRA, Leqembi, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, XHANCE, SHINGRIX.
Industry payments across TX — which companies pay providers there.
